TOURMALINE-MM3: Ixazomib improves PFS after myeloma transplantDecember 2, 2018Lymphoma & Plasma Cell Disorders
JULIET: CAR T cells go the distance in r/r DLBCLDecember 2, 2018Lymphoma & Plasma Cell DisordersImmuno-oncology
Beat AML trial delivers genomic results in 7 daysDecember 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Gut bacteria influence HCT outcomesDecember 2, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
ELIANA update: Tisagenlecleucel responses durable in r/r B-cell ALLDecember 2, 2018Leukemia, Myelodysplasia, Transplantation
Ibrutinib outperforms bendamustine and rituximab in older CLL patientsDecember 2, 2018Leukemia, Myelodysplasia, Transplantation
MEDALIST: Erythroid maturation agent reduced transfusion burden in MDSDecember 1, 2018Leukemia, Myelodysplasia, Transplantation
FLYER: Four cycles of R-CHOP as good as six in low-risk DLBCLDecember 1, 2018Lymphoma & Plasma Cell Disorders
Stem cell transplant after CAR T cells may reduce B-ALL relapse riskDecember 1, 2018Leukemia, Myelodysplasia, TransplantationPediatrics
FLYER: R-CHOP 4 safer, as effective for low-risk DLBCL patients under 60December 1, 2018Lymphoma & Plasma Cell Disorders
CNS lymphoma guidelines stress patient fitness, not age, in choosing treatmentNovember 30, 2018Neuro-oncology
